Corner Posts



RADx Initiative: Bioengineering for COVID-19 at Unprecedented Speed and Scale

NIBIB Director Dr. Bruce Tromberg marks the two-year anniversary of RADx® Tech, and takes a brief look back at its formation, impact, and potential for future growth.

Bridge2AI: Call to the bioengineering community

NIBIB is proud to be one of the co-sponsors of the exciting new NIH Common Fund initiative Bridge2AI which aims to dramatically advance widespread adoption of artificial intelligence (AI) as a tool for biomedical research. As the director of the engineering institute at NIH, I am pleased to say that our community plays a special role in this initiative.

RADx One Year Later – A Sea Change for Diagnostics

A quiet healthcare revolution is taking place, driven by an urgent national need and fueled by cutting-edge technologies. Diagnostics have changed, and more COVID-19 tests are now performed in point of care (POC) and home settings than in central labs. NIBIB is now looking forward with the goal of leveraging this unprecedented transformation.

When to Test website adds new features: Guidance for K-12 and businesses

An innovative online tool funded by NIBIB helps organizations choose a COVID-19 testing strategy that will work best for their specific needs.

Multiple Reflections: looking forward, looking back

2021 is finally here and most of us are thrilled to put last year  in the rear-view mirror. Although the rollercoaster month of January hasn’t been the smoothest of starts, there are many positive signs that a brighter future is just around the corner.

Robust engineering response powers rapid progress toward thwarting pandemic

Several months ago in this space I wrote that bioengineered technologies for COVID-19 testing must ultimately be deployed to help reduce the spread of the virus and return us safely to full function as a society. Since then, through a massive response by the bioengineering community in support of the RADx initiative, we have awarded contracts worth $ 513.1 million to 25 small and large biomedical diagnostic companies for scale-up and manufacturing.

Social engineering and bioengineering together can thwart the COVID-19 pandemic

NIBIB's goal is to accelerate research, translation, and commercialization of technologies that will make a difference in the battle against COVID-19.

Leveraging Our Scientific Creativity — RADx-tech

The Business and Innovation blog of featured a post about Bruce Tromberg’s plenary talk at the Photonics West conference in San Francisco.

NIH harnesses AI for COVID-19 diagnosis, treatment, and monitoring

A multi-institutional collaboration, led by the NIBIB will create new tools that physicians can use for early detection and personalized therapies for COVID-19 patients.